Executive Summary
Azoth Analytics has released a research report titled "Global Core Clinical Molecular Diagnostics Market (2023 Edition)" which provides a complete analysis of the Global Core Clinical Molecular Diagnostics industry in terms of market segmentation By Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Others) and By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Other Applications) for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 11 countries (United States, Canada, United Kingdom, Germany, Italy, France, Spain, China, India, Japan, Australia). Additionally, the research report presents data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research study also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.
During the forecast period, 2024-2029, the Global Core Clinical Molecular Diagnostics market is expected to grow at a CAGR of 10.7%. The Global Core Clinical Molecular Diagnostics Market is expected to generate USD 11.04 billion by the end of 2029, up from USD 4.9 Billion in 2022.
Clinical Molecular diagnostics is a rapidly expanding market that encompasses a wide range of applications, including infectious illnesses, cancer, hematopathology, clinical chemistry, and clinical genetics. The increasing prevalence of chronic diseases coupled with the growing demand for advanced diagnostic solutions for early disease detection are driving the market growth.
Additionally, the increasing awareness of personalized treatment and direct-to-consumer genetic testing is also supporting the market growth.
Moreover, the rising global prevalence of infectious diseases has significantly contributed to the demand for clinical molecular diagnostics solutions, wherein polymerase chain reaction (PCR) testing has emerged as the primary method for detecting COVID-19. The application of polymerase chain reaction (PCR) testing has played a significant role in enhancing the field of molecular diagnostics for infectious diseases, specifically in nucleic acid-based methodologies. As a result, this particular segment has emerged as one of the most prominent segments within the core clinical molecular diagnostics market.
Scope of the Report:
• The report analyses the Core Clinical Molecular Diagnostics Market by Value (USD Billion).
• The report presents the analysis of Core Clinical Molecular Diagnostics Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.
• The report analyses the Core Clinical Molecular Diagnostics Market by Application (Infectious disease and blood screening, Genetic testing, Cancer Screening Other Applications).
• The report analyses the Core Clinical Molecular Diagnostics Market by Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Other Technologies).
• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by Region, by Application & by Technologies.
• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Merck Group (SigmaAldrich Co., LLC), F. Hoffmann-La Roche AG, Agilent technologies, PerkinElmer Inc., Abbott Laboratories, QIAGEN, Thermo Fisher Scientific, Becton, Dickinson and Company, Hologic, Inc., Danaher Corporation.
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Strategic Recommendations
2.1 Integration of AI and Data Analytics to deliver highly accurate and rapid results
2.2 Partnerships with Academic Institutes
3. Global Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
3.1 Age-standardised cancer incidence rate, 2020*
3.2 SARS-Cov-2 Tests: Volumes 2020
3.3 Molecular diagnostics undergoing Clinical trials
3.4 Global Core Clinical Molecular Diagnostics Market: Dashboard
3.5 Global Core Clinical Molecular Diagnostics Market: Market Value Assessment, 2019-2029 (USD Billion)
3.6 Impact of COVID-19 on the Global Core Clinical Molecular Diagnostics Market
3.7 Global Core Clinical Molecular Diagnostics Market Segmentation: By Application
3.7.1 Global Core Clinical Molecular Diagnostics Market, By Application Overview
3.7.2 Global Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.3 Global Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.4 Global Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
3.7.5 Global Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
3.8 Global Core Clinical Molecular Diagnostics Market Segmentation: By Technology
3.8.1 Global Core Clinical Molecular Diagnostics Market, By Technology Overview
3.8.2 Global Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.3 Global Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.4 Global Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
3.8.5 Global Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
4. Global Core Clinical Molecular Diagnostics Market, Region Analysis
4.1 Regional Coverage of the Study
5. Americas Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
5.1 Americas Core Clinical Molecular Diagnostics Market: Snapshot
5.2 Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.3 Americas Core Clinical Molecular Diagnostics Market: Key Factors
5.4 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Application
5.4.1 Americas Core Clinical Molecular Diagnostics Market, By Application Overview
5.4.2 Americas Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.3 Americas Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.4 Americas Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
5.4.5 Americas Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
5.5 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Technology
5.5.1 Americas Core Clinical Molecular Diagnostics Market, By Technology Overview
5.5.2 Americas Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.3 Americas Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.4 Americas Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
5.5.5 Americas Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
5.6 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Country
5.6.1 United States Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.1.1 United States Core Clinical Molecular Diagnostics Market, By Application
5.6.1.2 United States Core Clinical Molecular Diagnostics Market, By Technology
5.6.2 Canada Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.2.1 Canada Core Clinical Molecular Diagnostics Market, By Application
5.6.2.2 Canada Core Clinical Molecular Diagnostics Market, By Technology
5.6.3 Rest of Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
5.6.3.1 Rest of Americas Core Clinical Molecular Diagnostics Market, By Application
5.6.3.2 Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology
6. Europe Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
6.1 Europe Core Clinical Molecular Diagnostics Market: Snapshot
6.2 Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.3 Europe Core Clinical Molecular Diagnostics Market: Key Factors
6.4 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Application
6.4.1 Europe Core Clinical Molecular Diagnostics Market, By Application Overview
6.4.2 Europe Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.3 Europe Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.4 Europe Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
6.4.5 Europe Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
6.5 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Technology
6.5.1 Europe Core Clinical Molecular Diagnostics Market, By Technology Overview
6.5.2 Europe Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.3 Europe Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.4 Europe Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
6.5.5 Europe Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
6.6 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Country
6.6.1 France Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.1.1 France Core Clinical Molecular Diagnostics Market, By Application
6.6.1.2 France Core Clinical Molecular Diagnostics Market, By Technology
6.6.2 United Kingdom Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.2.1 United Kingdom Core Clinical Molecular Diagnostics Market, By Application
6.6.2.2 United Kingdom Core Clinical Molecular Diagnostics Market, By Technology
6.6.2 Italy Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.2.1 Italy Core Clinical Molecular Diagnostics Market, By Application
6.6.2.2 Italy Core Clinical Molecular Diagnostics Market, By Technology
6.6.3 Spain Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.3.1 Spain Core Clinical Molecular Diagnostics Market, By Application
6.6.3.2 Spain Core Clinical Molecular Diagnostics Market, By Technology
6.6.4 Germany Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.4.1 Germany Core Clinical Molecular Diagnostics Market, By Application
6.6.4.2 Germany Core Clinical Molecular Diagnostics Market, By Technology
6.6.5 Rest of Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
6.6.5.1 Rest of Europe Core Clinical Molecular Diagnostics Market, By Application
6.6.5.2 Rest of Europe Core Clinical Molecular Diagnostics Market, By Technology
7. Asia-Pacific Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
7.1 Asia-Pacific Core Clinical Molecular Diagnostics Market: Snapshot
7.2 Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.3 Asia-Pacific Core Clinical Molecular Diagnostics Market: Key Factors
7.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Application
7.4.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application Overview
7.4.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
7.4.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
7.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Technology
7.5.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology Overview
7.5.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
7.5.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
7.6 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Country
7.6.1 China Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.1.1 China Core Clinical Molecular Diagnostics Market, By Application
7.6.1.2 China Core Clinical Molecular Diagnostics Market, By Technology
7.6.2 Japan Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.2.1 Japan Core Clinical Molecular Diagnostics Market, By Application
7.6.2.2 Japan Core Clinical Molecular Diagnostics Market, By Technology
7.6.3 India Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.3.1 India Core Clinical Molecular Diagnostics Market, By Application
7.6.3.2 India Core Clinical Molecular Diagnostics Market, By Technology
7.6.4 Australia Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.4.1 Australia Core Clinical Molecular Diagnostics Market, By Application
7.6.4.2 Australia Core Clinical Molecular Diagnostics Market, By Technology
7.6.5 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
7.6.5.1 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application
7.6.5.2 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology
8. Middle-East & Africa Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)
8.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Snapshot
8.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)
8.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Key Factors
8.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Application
8.4.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Application Overview
8.4.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)
8.4.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Technology
8.5.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Technology Overview
8.5.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)
8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)
9. Market Dynamics
9.1 Impact Assessment of Market Dynamics on Global Core Clinical Molecular Diagnostics Market
9.2 Drivers
9.3 Restraints
9.4 Trends
10. Porter's Five Forces Analysis
10.1 Porter's Five Forces Model
11. Competitive Positioning
11.1 Companies' Product Positioning
11.2 Market Position Matrix
11.3 Market Share Analysis of Core Clinical Molecular Diagnostics Market
11.4 Company Profiles
11.4.1 Merck Group (SigmaAldrich Co., LLC)
11.4.2 F. Hoffmann-La Roche AG
11.4.3 Agilent technologies
11.4.4 PerkinElmer Inc.
11.4.5 Abbott Laboratories
11.4.6 QIAGEN
11.4.7 Thermo Fisher Scientific
11.4.8 Becton, Dickinson and Company
11.4.9 Hologic, Inc.
11.4.10 Danaher Corporation
The Decentralized Clinical Research Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive land...
The Decentralized Clinical Trial Solution Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
The Clinical Workflow Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Clinical Trial Translation Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The Medical Clinical Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
Executive Summary
Azoth Analytics has released a research report titled "Global Infectious Disease In vitro Diagnostics Market (2024 Edition)" which provides a complete analysis of the Global Infectious Disease In vitro Diagnostics industry in terms of market segmentation By Technology ...
The Mobile Clinical Information System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...
The In Vitro Diagnostics (IVD) Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Molecular Biology Enzymes Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...
The Core Liquid Filter Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers/pl...